Product NDC: | 0173-0601 |
Proprietary Name: | FLOVENT |
Non Proprietary Name: | fluticasone propionate |
Active Ingredient(s): | 250 ug/1 & nbsp; fluticasone propionate |
Administration Route(s): | RESPIRATORY (INHALATION) |
Dosage Form(s): | POWDER, METERED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0601 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020833 |
Marketing Category: | NDA |
Start Marketing Date: | 20081013 |
Package NDC: | 0173-0601-01 |
Package Description: | 28 POWDER, METERED in 1 INHALER (0173-0601-01) |
NDC Code | 0173-0601-01 |
Proprietary Name | FLOVENT |
Package Description | 28 POWDER, METERED in 1 INHALER (0173-0601-01) |
Product NDC | 0173-0601 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | fluticasone propionate |
Dosage Form Name | POWDER, METERED |
Route Name | RESPIRATORY (INHALATION) |
Start Marketing Date | 20081013 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | FLUTICASONE PROPIONATE |
Strength Number | 250 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |